Search

Author/Creator Reau, Nancy

1. 99.7% Sustained Virologic Response Rate in 369 HCV Genotype 1b‐Infected Patients Treated With Label‐Recommended Regimen of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin: 2016. (October 2015)

Authors:
Jacobson, Ira M.; Dufour, Jean‐Francois; Wedemeyer, Heiner; Bernstein, David; Colombo, Massimo; Romero‐ Gómez, Manuel; Reau, Nancy; Trinh, Roger; Xie, Wangang; Enejosa, Jeffrey; Cohen, Daniel; Martinez, Marisol
Journal:
American journal of gastroenterology
Issue:
Volume 110(2015)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. An international survey on patterns of practice in NAFLD and expectations for therapies—The POP‐NEXT project. Issue 6 (26th April 2022)

Authors:
Ratziu, Vlad; Anstee, Quentin M.; Wong, Vincent Wai‐Sun; Schattenberg, Jörn M.; Bugianesi, Elisabetta; Augustin, Salvador; Gheorghe, Liana; Zambon, Vittoria; Reau, Nancy
Journal:
Hepatology
Issue:
Volume 76:Issue 6(2022)
Page Start:
1766
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: A pooled analysis of 1, 322 patients with hepatitis C infection. Issue 8 (22nd August 2017)

Authors:
Reau, Nancy; Robertson, Michael N.; Feng, Hwa‐Ping; Caro, Luzelena; Yeh, Wendy W.; Nguyen, Bach‐Yen T.; Wahl, Janice; Barr, Eliav; Hwang, Peggy; Klopfer, Stephanie O.
Journal:
Hepatology communications
Issue:
Volume 1:Issue 8(2017)
Page Start:
757
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗